Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Kickbacks: Does OIG Green Light of Free Product Replacements Open Door for Lab Freebies?
...
Register
Company of the Month: Interpace Diagnostics
...
Register
Reimbursement Trends: 8 Molecular Assays Score Big Coverage Wins from Medicare, Private Insurers
...
Register
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
...
Register
Case of the Month: Court Says Labs Must Verify Medical Necessity of Tests that Physicians Order
...
Register
Medicare Reimbursement: CMS Issues New Medical Review Instructions to Contractors
...
Register
Medicare Reimbursement: 4 Molecular Assays Score Big Coverage Wins
...
Register
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
From - Laboratory Industry Report
Strategic alliance rather than M&A remains the preferred form of strategic interaction in the lab industry…
Annual TB Testing of Health Care Workers Not Cost Effective
From - Diagnostic Testing & Emerging Technologies
Routine annual tuberculosis (TB) screening of health care workers is no longer cost effective, according to a study published May 17 in BMC Medicine. The incidence of…
OIG Work Plan Monthly Review: September 2017
From - G2 Compliance Advisor
Many of the 12 new items that the OIG added to its 2017 Work Plan in September target state and federal government agencies, including the…